HLA-haploidentical bone marrow transplantation for severe combined immunodeficiency using E rosette fractionation and cyclosporine.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Blood

• Publication date

  1986-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD.V67.2.444.444PMID 3510681
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency.

  1985cited by this paper
• Immunoreconstitution in severe combined immunodeficiency after transplantation of HLA-haploidentical, T-cell-depleted bone marrow.

  1984cited by this paper
• Lymphomas and lymphoproliferative lesions developing under cyclosporin therapy.

  1984cited by this paper
• Bone-marrow transplantation for inborn error of phagocytic cells associated with defective adherence, chemotaxis, and oxidative response during opsonised particle phagocytosis.

  1983cited by this paper
• Application of bone marrow transplantation in genetic diseases.

  1983cited by this paper
• IMMUNOLOGIC REACTIVITY IN MARROW GRAFT RECIPIENTS RECEIVING CYCLOSPORINE TO PREVENT GRAFT‐VERSUS‐HOST DISEASE

  1983cited by this paper
• Bone marrow transplantation--an expanding approach to treatment of many diseases.

  1983cited by this paper
• Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells.

  1983cited by this paper
• Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency.

  1982cited by this paper
• Effect of cyclosporin A on human lymphocyte responses in vitro. IV. Production of T cell stimulatory growth factors and development of responsiveness to these growth factors in CsA-treated primary MLR cultures.

  1982cited by this paper
• Failure of a pan-reactive anti-T cell antibody, OKT 3, to prevent graft versus host disease in severe combined immunodeficiency.

  1982cited by this paper
• Immunoglobulins in ataxia-telangiectasia: evidence for IgG4 and IgA2 subclass deficiencies.

  1981cited by this paper
• Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation.

  1980cited by this paper
• Lymphoma after thymus transplantation.

  1980cited by this paper
• Monoclonal antibodies defining distinctive human T cell surface antigens.

  1979cited by this paper
• Fatal lymphoma after transplantation of cultured thymus in children with combined immunodeficiency disease.

  1979cited by this paper
• Bone marrow transplantation for severe combined immunodeficiency disease

  1979cited by this paper
• Selective defect of precursor T cells associated with apparently normal B lymphocytes in severe combined immunodeficiency disease.

  1978cited by this paper
• Immunological reconstitution of sex-linked lymphopenic immunological deficiency.

  1968cited by this paper
• FAMILIAL RETICULOENDOTHELIOSIS WITH EOSINOPHILIA.

  1965cited by this paper

• The rationale behind grafting haploidentical hematopoietic stem cells

  2024cites this paper
• Hematopoietic stem cell transplantation for primary immune deficiencies

  2020cites this paper
• T Cell-Depleted and T Cell-Replete HLA-Haploidentical Stem Cell Transplantation for Non-malignant Disorders

  2017cites this paper
• Comparable Allogeneic Hematopoietic Cell Transplantation Outcome of a Haplo-Identical Family Donor with an Alternative Donor in Adult Aplastic Anemia

  2016cites this paper
• Hematopoietic Stem Cell Transplantation for Primary Immunodeficiency

  2014cites this paper
• Use of V(D)J recombination excision circles to identify T- and B-cell defects and to monitor the treatment in primary and acquired immunodeficiencies

  2013cites this paper
• HLA-haploidentical donor transplantation in severe combined immunodeficiency.

  2011cites this paper
• murine recipients by granulocyte/macrophage colony-stimulating factor Augmentation of donor bone marrow engraftment in histoincompatible

  2011cites this paper
• Haploidentical bone marrow transplantation in primary immune deficiency: stem cell selection and manipulation.

  2011cites this paper
• The outcomes of family haploidentical hematopoietic stem cell transplantation in hematologic malignancies are not associated with patient age.

  2011cites this paper
• Syndromes hémophagocytaires d'origine génétique

  2010cites this paper
• Crossing hla barriers by “megadose” stem cell transplants

  2010cites this paper
• HLA-haploidentical donor transplantation in severe combined immunodeficiency.

  2010cites this paper
• Haploidentical bone marrow transplantation in primary immune deficiency: stem cell selection and manipulation.

  2010cites this paper
• class II deficiency: a single-center study of 19 patients Bone marrow transplantation in major histocompatibility complex

  2010cites this paper
• Induction of tolerance in organ recipients by hematopoietic stem cell transplantation.

  2009cites this paper
• Hematopoietic Cell Transplantation for Immunodeficiency Diseases

  2009cites this paper
• cells with monoclonal antibody CT-2 and complement marrow transplantation for immune deficiency disorders: treatment of bone Immunologic reconstitution after haploidentical bone marrow

  2009cites this paper
• Allogeneic Hematopoietic Cell Transplantation from an HLA-mismatched Family Donor: The Current Status and Future

  2009cites this paper
• Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.

  2009cites this paper
• Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation.

  2008cites this paper
• T cell repertoire development in XSCID dogs following nonconditioned allogeneic bone marrow transplantation.

  2007cites this paper
• Trasplante de células progenitoras hematopoyéticas en pediatría: Una alternativa de tratamiento en inmunodeficiencias primarias

  2005cites this paper
• T-Cell-Depleted CD34+ Cell Transplantation From an HLA-Mismatched Donor in a Low-Birthweight Infant With X-Linked Severe Combined Immunodeficiency

  2005cites this paper
• [Hematopoietic stem cell transplant in combined immunodeficiency syndromes of childhood: an optimal treatment for primary immunodeficiency].

  2005cites this paper
• Haploidentical transplantation for acute lymphoblastic leukemia in childhood.

  2004cites this paper
• Severe Combined Immunodeficiency: A Case Report and Literature Review

  2004cites this paper
• An immunotoxin containing a rat IgM monoclonal antibody (Campath 1) and saporin 6: effect on T lymphocytes and hemopoietic cells

  2004cites this paper
• A historical review of bone marrow transplantation for immunodeficiencies.

  2004cites this paper
• Nonmyeloablative allogeneic stem cell transplantation using alternative donors.

  2004cites this paper
• Haploidentical Stem Cell Transplantation

  2004cites this paper
• Depletion of Host Reactive T Cells by Photodynamic Cell Purging and Prevention of Graft Versus Host Disease

  2003cites this paper
• Hematopoietic stem cell transplantation across major genetic barriers

  2003cites this paper
• Megadose of hematopoietic stem cells for haploidentical transplants

  2002cites this paper
• The DiGeorge anomaly

  2001cites this paper
• The DiGeorge anomaly.

  2001cites this paper
• Bone marrow transplantation across major genetic barriers: the role of megadose stem cells and nonalloreactive donor anti-third party CTLS.

  2001cites this paper
• Tolerance induction by 'megadose' transplants of CD34+ stem cells: a new option for leukemia patients without an HLA-matched donor.

  2000cites this paper
• Allogeneic peripheral blood stem cell transplantation following CD34+ enrichment by density gradient separation

  2000cites this paper
• T cell depleted haploidentical bone marrow transplantation for the treatment of children with severe combined immunodeficiency.

  2000cites this paper
• Matched unrelated bone marrow transplantation for combined immunodeficiency

  2000cites this paper
• HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR SEVERE COMBINED IMMUNODEFICIENCY DISEASE

  2000cites this paper
• Stem cell escalation enables HLA-disparate haematopoietic transplants in leukaemia patients.

  1999cites this paper
• Long-term chimerism and B-cell function after bone marrow transplantation in patients with severe combined immunodeficiency with B cells: A single-center study of 22 patients.

  1999cites this paper
• The DiGeorge anomaly (CATCH 22, DiGeorge/velocardiofacial syndrome).

  1998cites this paper
• Long-term T cell immune reconstitution in 2 SCID patients after BMT.

  1998cites this paper
• Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients.

  1998cites this paper
• Hepatic GVHD after HLA‐haploidentical bone marrow transplantation in children with severe combined immunodeficiency: the effect of ursodeoxycholic acid

  1997cites this paper
• Full immunologic reconstitution following nonconditioned bone marrow transplantation for canine X-linked severe combined immunodeficiency.

  1997cites this paper
• In vitro T cell depletion using Campath 1M for mismatched BMT for severe combined immunodeficiency (SCID)

  1997cites this paper
• Applications of hematopoietic stem cells and gene transfer.

  1996cites this paper
• Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.

  1996cites this paper
• Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome from a single center.

  1996cites this paper
• Bone marrow transplantation in immunodeficiency diseases.

  1996cites this paper
• Bone marrow transplantation in major histocompatibility complex class II deficiency: a single-center study of 19 patients.

  1995cites this paper
• Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation for (severe) combined immunodeficiency.

  1994cites this paper
• Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients.

  1993cites this paper
• [Development of the immune system].

  1992cites this paper
• Treatment Planning and Timing of Transplantation

  1992cites this paper
• Reduction of graft failure by a monoclonal antibody (anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis, and Fanconi's anemia: a European Group for Immunodeficiency/European Group for Bone Marrow Transplantation report.

  1991cites this paper
• The biology of bone marrow transplantation for severe combined immune deficiency.

  1991cites this paper
• Successful lectin-separated bone marrow transplantation in adenosine deaminase deficiency-related severe immunodeficiency.

  1990cites this paper
• European experience of bone-marrow transplantation for severe combined immunodeficiency.

  1990cites this paper
• Points to Consider Response with Clinical Protocol, July 6, 1990

  1990cites this paper
• Successful treatment with an unrelated-donor bone marrow transplant in an HLA-deficient patient with severe combined immune deficiency ("bare lymphocyte syndrome").

  1990cites this paper
• The use of locus-specific minisatellite probes to check engraftment following allogeneic bone marrow transplantation for severe combined immunodeficiency disease.

  1990cites this paper
• Pharmacology of cyclosporine (sandimmune). IV. Pharmacological properties in vivo.

  1989cites this paper
• Characterization of B cells in severe combined immunodeficiency disease.

  1989cites this paper
• Cost of allogeneic bone marrow transplantation in four diseases.

  1989cites this paper
• Development of immunologic functions after bone marrow transplantation in 33 patients with severe combined immunodeficiency.

  1989cites this paper
• HLA-haploidentical bone marrow transplantation in three infants with adenosine deaminase deficiency: Stable immunological reconstitution and reversal of skeletal abnormalities

  1989cites this paper
• In vivo infusion of anti LFA-1 antibody in HLA non-identical bone marrow transplantation in children: serum concentrations and biological effects.

  1989cites this paper
• Donor bone marrow treatment with T101 Fab fragment-ricin A-chain immunotoxin prevents graft-versus-host disease.

  1989cites this paper
• Hypoglycaemia induced by antibodies to insulin receptor following a bone marrow transplantation in an immunodeficient child

  1989cites this paper
• Successful HLA nonidentical bone marrow transplantation in three patients with the leukocyte adhesion deficiency.

  1989cites this paper
• Augmentation of donor bone marrow engraftment in histoincompatible murine recipients by granulocyte/macrophage colony-stimulating factor.

  1988cites this paper
• Treatment of severe Epstein-Barr virus-induced polyclonal B-lymphocyte proliferation by anti-B-cell monoclonal antibodies. Two cases after HLA-mismatched bone marrow transplantation.

  1988cites this paper
• Treatment of Severe Epstein-Barr Virus-Induced Polyclonal B-Lymphocyte Proliferation by Anti-B-Cell Monoclonal Antibodies: Two Cases After HLA-Mismatched Bone Marrow Transplantation

  1988cites this paper
• Ataxia—ocular motor aprilaxia: A syndrome mimicking ataxia‐telangiectasia

  1988cites this paper
• Bone marrow transplantation in children: 20 years after its first successful application.

  1988cites this paper
• Accelerated development of immunity following transplantation of maternal marrow stem cells into infants with severe combined immunodeficiency and transplacentally acquired lymphoid chimerism.

  1988cites this paper
• Bone marrow transplantation in the treatment of severe immunodeficiencies: possibilities and problems.

  1988cites this paper
• A Guide to Bone Marrow Transplantation

  1988cites this paper
• Marrow transplantation from HLA non‐identical family donors for the treatment of leukaemia: a pilot study of 15 patients using additional immunosuppression and T‐cell depletion

  1988cites this paper
• A new density gradient for the separation of large quantities of rosette-positive and rosette-negative cells.

  1987cites this paper
• Studies of human bone marrow treated with soybean lectin and sheep erythrocytes: stepwise analysis of cell morphology, phenotype and function.

  1987cites this paper
• [Prevention of the graft-versus-host disease by T-cell depletion in allogenic bone marrow transplantation].

  1987cites this paper
• Gene therapy using bone marrow transplantation.

  1987cites this paper
• Transplantation of marrow from donors other than genotypically HLA-identical siblings.

  1987cites this paper
• Pediatric Bone Marrow Transplantation: Intensive Care Management

  1987cites this paper
• Dissociation between onset of natural killer E-rosette forming cells and of T3-positive cells following HLA-mismatched T cell depleted bone marrow transplantation.

  1987cites this paper
• Bone marrow transplantation in the treatment of primary immunodeficiencies.

  1987cites this paper
• Bone-marrow transplantation for immunodeficiencies and osteopetrosis: European survey, 1968-1985.

  1986cites this paper
• Anti-CD2 (T, p50) intact ricin immunotoxins for GVHD-prophylaxis in allogeneic bone marrow transplantation.

  1986cites this paper
• Prevention of graft failure by an anti-HLFA-1 monoclonal antibody in HLA-mismatched bone-marrow transplantation.

  1986cites this paper
• Aids and Related Syndromes As a Viral-induced Autoimmune Disease of the Immune System: an Anti-MHC II Disorder. Therapeutic Implications

  1986cites this paper
• Successful donor cell engraftment in a recipient of bone marrow from a cadaveric donor.

  1986cites this paper
• Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis.

  1986cites this paper
• Restriction fragment length polymorphisms as markers of engraftment in allogeneic marrow transplantation.

  1985cites this paper